Significance of lymph node metastases in patients with pancreatic cancer undergoing curative resection**

https://doi.org/10.1016/S0002-9610(96)00237-1Get rights and content

Background

Recent reports suggest an improved survival following resection for patients with pancreatic carcinoma. However, the prognosis for patients with lymph nodes metastases remains uncertain. The purpose of this study was to determine if the presence of lymph node metastases significantly alters survival in patients with otherwise potentially curable pancreatic carcinoma.

Patients and Methods

Between 1970 and 1995, 401 patients with pancreatic adenocarcinoma, including 327 patients with pancreatic head tumors, were evaluated and treated.

Results

One hundred (31%) patients underwent pancreatoduodenectomy. Operative mortality was 3% and morbidity was 22%. Median survival for 97 patients discharged from the hospital following resection was 14 months (range 2 to 293). The estimated 1-, 2-, and 5-year survivals were 61%, 43%, and 20%, respectively. Median survival was 11.5 months (range 2 to 87) for patients with positive lymph nodes (n = 56) and 24 (range 0 to 293) months for patients with negative lymph nodes (n = 41; P = 0.0003). Ten patients (10%) survived longer than 5 years, and 9 (90%) of them had negative lymph nodes. Elderly patients (≥70 years) had a median survival twice as long as younger patients (24 versus 12 months, P = 0.03).

Conclusions

Lymph node metastases are found in 56% of patients undergoing resection. Pancreatoduodenectomy can be performed with low operative mortality in patients of all ages. It offers good palliation for patients with lymph nodes metastases and encouraging long-term survival rates as well as a chance for cure in patients with negative lymph nodes.

References (26)

  • NiteckiSS et al.

    Long-term survival after resection for ductal adenocarcinoma of the pancreas: is it really improving?

    Ann Surg

    (1995)
  • TredeM et al.

    Survival after pancreatoduodenectomy

    Ann Surg

    (1990)
  • MannellA et al.

    Factors influencing survival after resection for ductal adenocarcinoma of the pancreas

    Ann Surg

    (1986)
  • Cited by (89)

    • Long-term outcomes following en bloc resection for pancreatic ductal adenocarcinoma of the head with portomesenteric venous invasion

      2021, Asian Journal of Surgery
      Citation Excerpt :

      Pancreatic ductal adenocarcinoma (PDAC) is generally considered a very aggressive disease because it frequently extends beyond the pancreas, leading to involvement of the peripancreatic major vessels, lymph nodes and distant metastasis.1–10

    • The lymphatic system and pancreatic cancer

      2016, Cancer Letters
      Citation Excerpt :

      Unfortunately, most PDAC cases are diagnosed when the primary tumor has already spread to regional and distant locations [1] eliminating surgery as a curative treatment option. Cancer metastasis into and through the lymphatic vasculature and lymph nodes occurs frequently in PDAC patients [3–5] and is strongly correlated with poor prognosis [6–9]. Evaluating lymph node status has been proven to be a significant factor when determining therapy selection for cancer patients [10–12].

    • Pancreas

      2009, Modern Surgical Pathology
    • Pancreas

      2009, Modern Surgical Pathology
    View all citing articles on Scopus
    **

    Presented at the 48th Annual Meeting of the Southwestern Surgical Congress, Scottsdale, Arizona, April 28–May 1, 1996.

    View full text